tiprankstipranks
Inovio Pharmaceuticals (INO)
NASDAQ:INO

Inovio Pharmaceuticals (INO) Income Statement

5,611 Followers

Inovio Pharmaceuticals Income Statement

Last quarter (Q4 2023), Inovio Pharmaceuticals's total revenue was $102.65K, a decrease of -17.66% from the same quarter last year. In Q4, Inovio Pharmaceuticals's net income was $-23.99M. See Inovio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 832.01K$ 832.01K$ 10.26M$ 1.77M$ 7.41M$ 4.11M
Cost of Revenue
------
Gross Profit
$ 832.01K$ 832.01K$ 10.26M$ 1.77M--
Operating Expense
$ 144.77M$ 144.77M$ 277.84M$ -302.99M$ 131.49M$ 115.22M
Operating Income
$ -143.94M$ -143.94M$ -267.57M$ -301.22M$ -124.08M$ -111.11M
Net Non Operating Interest Income Expense
$ -606.15K$ -1.22M$ -1.25M$ -1.94M$ -5.39M$ -5.34M
Other Income Expense
$ -1.19M$ -1.19M$ 13.87M$ 3.87M$ -33.42M$ -4.36M
Pretax Income
$ -135.12M$ -135.12M$ -277.65M$ -303.22M$ -162.89M$ -120.81M
Tax Provision
$ -3.92M$ -3.92M$ -3.60M-$ 0.00$ -257.33K
Earnings From Equity Interest Net Of Tax
--$ -2.17M$ -987.96K$ -4.58M$ 0.00
Net Income Common Stockholders
$ -134.29M$ -135.10M$ -277.92M$ -303.66M$ -166.41M$ -119.36M
Basic EPS
$ -1.52$ -6.09$ -1.17$ -1.45$ -1.07$ -1.21
Diluted EPS
$ -1.52$ -6.09$ -1.17$ -1.45$ -1.07$ -1.21
Basic Average Shares
$ 814.16M$ 22.17M$ 238.62M$ 208.83M$ 155.13M$ 98.72M
Diluted Average Shares
$ 814.16M$ 22.17M$ 238.62M$ 208.83M$ 155.13M$ 98.72M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 144.77M$ 144.77M$ 277.84M$ -302.99M$ 131.49M$ 115.22M
Net Income From Continuing And Discontinued Operation
$ -135.10M$ -135.10M$ -279.82M$ -303.66M$ -166.41M$ -119.36M
Normalized Income
$ -73.76M$ -128.99M$ -282.35M-$ -97.14M$ -117.60M
Interest Expense
----$ 8.70M$ 7.95M
EBIT
$ -133.89M$ -133.89M$ -276.40M$ -301.29M$ -154.19M$ -112.86M
EBITDA
$ -97.83M$ -130.41M$ -270.90M$ -296.56M$ -149.56M$ -107.34M
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis